Results 31 to 40 of about 7,804 (207)

Facility-Associated Release of Polioviruses into Communities—Risks for the Posteradication Era

Emerging Infectious Diseases, 2019
The Global Polio Eradication Initiative continues to make progress toward the eradication target. Indigenous wild poliovirus (WPV) type 2 was last detected in 1999, WPV type 3 was last detected in 2012, and over the past 2 years WPV type 1 has been ...
Ananda S. Bandyopadhyay, Harpal Singh, Jacqueline Fournier-Caruana, John F. Modlin, Jay Wenger, Jeffrey Partridge, Roland W. Sutter, Michel J. Zaffran   +7 more
doaj   +1 more source

Inferring Numbers of Wild Poliovirus Excretors Using Quantitative Environmental Surveillance

Vaccines, 2021
Response to and monitoring of viral outbreaks can be efficiently focused when rapid, quantitative, kinetic information provides the location and the number of infected individuals. Environmental surveillance traditionally provides information on location
Yuri Perepliotchikov, Tomer Ziv-Baran, Musa Hindiyeh, Yossi Manor, Danit Sofer, Jacob Moran-Gilad, Laura Stephens, Ella Mendelson, Merav Weil, Ravit Bassal, Emilia Anis, Shepherd Roee Singer, Ehud Kaliner, Gillian Cooper, Manasi Majumdar, Michal Markovich, Daniela Ram, Itamar Grotto, Ronni Gamzu, Javier Martin, Lester M. Shulman   +20 more
doaj   +1 more source

Two-year duration of immunity of inactivated poliovirus vaccine: A follow-up study in Pakistan in 2020

, 2023
This was a follow-up study conducted in 2020 assessing changes in levels of type 2 poliovirus-neutralizing antibodies two years post-immunization in children who received inactivated poliovirus vaccine (IPV) in Karachi, Pakistan.
Macklin, Grace, Kazi, Zaubina, Pethani, Asma Sadruddin, Parkar, Sadia, Cavestany, Rocio Lopez, Saleem, Ali Faisal, Zehra, Syeda Mahjabeen, Zhang, Yiting, Mainou, Bernardo A, Jeyaseelan, Visalakshi   +9 more
core   +1 more source

Decay of Sabin inactivated poliovirus vaccine (IPV)-boosted poliovirus antibodies

, 2015
IntroductionWe conducted a follow-on study to a phase I randomized, controlled trial conducted in Cuba, 2012, to assess the persistence of poliovirus antibodies at 21–22months following booster dose of Sabin-IPV compared to Salk-IPV in adults who had ...
Fonseca, Magile, Sein, Carolyn, Resik, Sonia, Tejeda, Alina, Okayasu, Hiromasa, Sutter, Roland W., Hung, Lai Heng, Diaz, Manuel, Martinez, Yenisleidys   +8 more
core   +1 more source

Formaldehyde-inactivated human enterovirus 71 vaccine is compatible for co-immunization with a commercial pentavalent vaccine

, 2011
[[abstract]]In this study we tested the effectiveness of a formaldehyde-inactivated EV71 vaccine and its compatibility for co-immunization with a pentavalent vaccine that contained inactivated poliovirus (PV) vaccine.
Chen, CW;Lee, YP;Wang, YF;Yu, CK
core   +1 more source

Pediatric case with vaccine-related poliovirus infection: A case report

, 2021
BACKGROUND As long as oral poliovirus vaccine (OPV) is used, the potential risk for the emergence of vaccine-related polioviruses remains. CASE SUMMARY We report a case of Sabin-like type 1 poliovirus infection in an immunocompetent 17-mo-old child after
Farshadpour, F, Taherkhani, R
core   +1 more source

Identification Epitope on VP4 Protein of Senecavirus A Recognized by a Monoclonal Antibody

Animal Research and One Health, EarlyView.
This study aims to identify conserved antigenic epitopes on the SVA VP4 protein using monoclonal antibodies, providing valuable tools for further exploring its functions and developing detection methods. SVA VP4 protein was expressed in Escherichia coli and purified with High‐Affinity Ni‐Charged Resin FF.
Liang Meng, Xuyan Xiang, Xinyu Qi, Hanrong Zhou, Peiyu Xiao, Fandan Meng, Tongqing An, Haiwei Wang   +7 more
wiley   +1 more source

Ascertainment of childhood vaccination histories in northern Malawi.

, 2008
OBJECTIVE: To assess factors related to recorded vaccine uptake, which may confound the evaluation of vaccine impact. METHODS: Analysis of documented vaccination histories of children under 5 years and demographic and socio-economic characteristics ...
Mwinuka, V, Mwagomba, D., Crampin, A.C., McGrath, N, J. Mwafilaso, A. Jahn, Karsulukuta, A., Khunga, A, P. E. M. Fine, Mkisi, RE, Branson, K, A. Katsulukuta, Floyd, S., A. C. Crampin, K. Branson, V. Mwinuka, Branson, K., Fine, P.E.M., Mwafilaso, J., McGrath, N., D. Mwagomba, Khunga, A., S. Floyd, Katsulukuta, A, A. Khunga, Mwafilaso, J, N. McGrath, Jahn, A, Jahn, A., Mwinuka, V., R. E. Mkisi, Crampin, AC, Mwagomba, D, Mkisi, R.E., Katsulukuta, A., Fine, PEM, Floyd, S   +36 more
core   +1 more source

Detection of vaccine-derived poliovirus type-3 in sewage of Kathmandu Valley, Nepal

Clinical Infection in Practice
Enteroviruses include polioviruses, which are classified into three types: type 1, type 2, and type 3. The oral polio vaccine (OPV), which contains attenuated strains of these three types, has been pivotal in reducing polio incidence worldwide.
Rachana Mehta, Amrendra Kushwaha, Sanjit Sah, Jack Feehan, Vasso Apostolopoulos   +4 more
doaj   +1 more source

Immunogenicity of Catch-Up Immunization with Conventional Inactivated Polio Vaccine among Japanese Adults

Vaccines, 2022
Most Japanese adults are vaccinated twice with the Sabin trivalent oral polio vaccine. Booster vaccination is recommended for Japanese travelers to polio-endemic/high-risk countries.
Shinji Fukushima, Takashi Nakano, Hiroyuki Shimizu, Atsuo Hamada   +3 more
doaj   +1 more source